New Publications on KRas and HER2

Have a look into our most recent publications on covalent inhibitors addressing mutant variants of KRas and HER2:

• KRasG12C inhibitors in clinical trials: a short historical perspective
• Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach